HMB-002

· Hemab ApS

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HMB-002, covering 2025-12-09 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing HMB-002 in Participants With Von Willebrand Disease [Phase 1, Phase 2]